Further, polymorphisms in CXCL16 and TLR4 may be significant risk factors for some regions and populations while mutations in IL-10 or IL-10 receptors are associated with severe very-early-onset IBD [12,13]. Here, TLR4 is linked to inflammatory bowel disease.